CDT Equity Financials - Benzinga

CDT Equity Inc

CDTNASDAQ

Trade with Public

Trade with Public

$0.9101

-0.57-38.51%

At close: Sep 2, 5:00 PM EST

$0.9599

0.04985.47%

After Hours: 4:43 PM EST

PRO

Why Is It Moving?™:CDT Equity shares are trading lower after the company announced that, follo...

Overview News Earnings Forecast EventsFinancialsSentiment Ownership Compare Stock Report

CDT Equity Financials

CDT Equity (CDT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Conduit Pharmaceuticals Q1 EPS $(5.56) Up From $(3.67 thousand) YoY

Conduit Pharmaceuticals (NASDAQ:CDT) reported quarterly losses of $(5.56) per share. This is a 99.85 percent increase over losses of $(3.67 thousand) per share from the same period last year.

Benzinga Newsdesk

PRO
CDT Equity Files For Non-Timely 10-K With U.S. SEC;For Year Ended Dec 31, 2025, Anticipates Net Loss Will Increase By About $(21.3M)

For the year ended December 31, 2025, the Registrant anticipates that the Registrant's net loss will increase by approximately $21.3 million compared to the year ended December 31, 2024, to approximately $39.1 million.

Benzinga Newsdesk

PRO
Conduit Pharmaceuticals Q1 EPS $(1.32) Up From $(5.00) YoY

Conduit Pharmaceuticals (NASDAQ:CDT) reported quarterly losses of $(1.32) per share. This is a 73.6 percent increase over losses of $(5.00) per share from the same period last year.

Benzinga Newsdesk

Dow Dips 500 Points; US Economy Adds 256,000 Jobs In December

Avi Kapoor

Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket

Shares of Rumble Inc.

Avi Kapoor

S&P 500 Moves Higher; BlackRock Reports Upbeat Results

Avi Kapoor